Tricyclic thrombin receptor antagonists

Details for Australian Patent Application No. 2003221932 (hide)

Owner Schering Corporation

Inventors Xia, Yan; Chackalamannil, Samuel; Greenlee, William J; Chelliah, Mariappan; Clasby, Martin C; Veltri, Enrico P; Wang, Yuguang

Agent Griffith Hack

Pub. Number AU-B-2003221932

PCT Number PCT/US03/11510

PCT Pub. Number WO2003/089428

Priority 60/373,072 16.04.02 US

Filing date 14 April 2003

Wipo publication date 3 November 2003

Acceptance publication date 22 November 2007

International Classifications

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 31/443 (2006.01)

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/373,072 16.04.02 US

11 December 2003 Application Open to Public Inspection

  Published as AU-B-2003221932

22 November 2007 Application Accepted

  Published as AU-B-2003221932

3 April 2008 Standard Patent Sealed

11 October 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Merck Sharp & Dohme Corp. . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003221933-Light guide within recessed housing

2003221931-Dietary methods for canine performance enhancement